Alphabet Inc. Lyell Immunopharma, Inc. Transaction History
Alphabet Inc.
- $1.12 Billion
- Q1 2025
A detailed history of Alphabet Inc. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 5,865,125 shares of LYEL stock, worth $2.58 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
5,865,125
Previous 5,865,125
-0.0%
Holding current value
$2.58 Million
Previous $3.75 Million
15.61%
% of portfolio
0.28%
Previous 0.27%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.87 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$7.04 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.64 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.64 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.94 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $109M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...